Treating atopic patients in a multidisciplinary setting
Excessive type 2 inflammation has emerged as a unifying feature in certain people living with inflammatory diseases such as asthma, atopic dermatitis and CRSwNP. These type 2 inflammatory diseases may appear disparate based on their distinct organ and tissue manifestations and are treated as such by a wide range of professionals within our healthcare systems. However, this classic fragmentation does not fit with the more recent insights addressing type 2 inflammatory diseases.
Focusing on the underlying pathway driving these diseases, recognized experts will share their knowledge for a better understanding of type 2 inflammation and treatment modalities. Giving rise to a new era of personalized therapy and the added value of a multi-disciplinary approach on how to treat these patients.
- Prof. dr. Wytske Fokkens, ENT-doctor, Amsterdam AMC locatie AMC
- Dr. Els Weersink, pulmonologist, Amsterdam AMC locatie VUmc
- Prof. dr. Hilde Lapeere, dermatologist, UZ Gent
- Prof. dr. Bart Lambrecht, pulmonologist, UZ Gent
- Dr. Edward Knol, biomedical scientist and immunologist, UMC Utrecht, moderator
This webcast will be broadcast on Tuesday the 16th of November 2021 from 19.30 – 21.00 PM.
This webcast is primarily intended for pulmonologists, ENT-physicians, dermatologists, allergists and pediatricians in the Netherlands and Belgium. Other interested healthcare professionals are welcome to join.
Accreditation has been requested from NVALT, Stichting KNO, NVDV, NVVA and NVK in the Netherlands and for healthcare professionals in Belgium.
Create an account or log in with your existing account on mednet.nl to join the webcast.
Participation in this webcast is free of charge.
If you have any questions, please send an email to email@example.com.
This webcast is sponsored by
In the context of GDPR, Springer complies with the laws and regulations as laid down by this law. For this webcast it applies that it concerns a collaboration between Springer and Sanofi and that they each determine their own purpose and means in the processing of personal data. Springer and Sanofi are therefore separately responsible for processing. The privacy conditions that apply can be found here: Springer Healthcare & Sanofi.